Cipargamin Could Inhibit Human Adenosine Receptor A3 with Higher Binding Affinity than Plasmodium falciparum P-type ATPase 4: An In Silico Study

New research publication:

Cipargamin Could Inhibit Human Adenosine Receptor A3 with Higher Binding Affinity than Plasmodium falciparum P-type ATPase 4: An In Silico Study

Link to download this research paper:

https://www.researchgate.net/publication/360259844_Cipargamin_Could_Inhibit_Human_Adenosine_Receptor_A3_with_Higher_Binding_Affinity_than_Plasmodium_falciparum_P-type_ATPase_4_An_In_Silico_Study

Signed,

Heze-Sapience International.
hezesapience(at)gmail.com

Unknown's avatar

Author: Toluwase Fatoki Center

Toluwase Fatoki is a training and consulting business entity involving in leading research in applied bioinformatics, biomarketing and principled leadership.